According to IMARC Group’s latest report, titled “Stroke Management Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global stroke management market reached a value of US$ 31.1 Billion in 2021. Stroke management is the process of evaluating and assessing patients with acute stroke. It relies on an echocardiogram, cerebral angiogram, carotid ultrasound, blood tests, magnetic resonance imaging (MRI), and computerized tomography (CT) scan and blood tests for a complete evaluation. As per the assessment and patient’s condition, it assists physicians in opting for treatment options like endovascular procedures, intubation, intravenous (IV) medication, and surgeries.
Request for a PDF sample of this report: https://www.imarcgroup.com/stroke-management-market/requestsample
Presently, there is a growing prevalence of chronic diseases, such as migraine, hypertension, diabetes, obesity, and cardiac diseases around the world. This, in confluence with the excessive drug and alcohol consumption, physical inactivity, and unhealthy diets of individuals, represents one of the key factors strengthening the market growth. Besides this, a significant rise in the geriatric population, which is relatively more vulnerable to stroke, is escalating catalyzing the demand for efficient stroke management worldwide. Furthermore, governing agencies of various countries are launching public health programs to encouraging individuals to emphasize the importance of have periodic screening examinations. This, along with increasing awareness about the benefits of early diagnosis and treatment, is driving the market. Looking forward, IMARC Group expects the stroke management market to reach US$ 46.8 Billion by 2027, exhibiting a CAGR of 6.97% during 2022-2027.
Checkout Now: https://www.imarcgroup.com/checkout?id=4313&method=1
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Competitive Landscape with Key Players:
- Abbott Laboratories
- Braun Melsungen AG
- Boston Scientific Corporation
- Bristol-Myers Squibb Company
- Cardinal Health
- General Electric Company
- GlaxoSmithKline plc
- Medtronic plc
- Merck & Co. Inc.
- Siemens Healthineers AG (Siemens AG).
Breakup by Type:
- Computed Tomography Scan (CT Scan)
- Magnetic Resonance Imaging (MRI)
- Carotid Ultrasound
- Cerebral Angiography
- Tissue Plasminogen Activator
Breakup by Application:
- Ischemic Stroke
- Haemorrhagic Stroke
Breakup by End User:
- Ambulatory Surgical Centers
- Diagnostic Centers
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/stroke-management-market
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800